Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

31 Jul 2012 07:00

RNS Number : 8643I
Creston PLC
31 July 2012
Β 

ο»Ώ

31 July 2012

Β 

Creston plc

Interim Management Statement

Β 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2012 to date.

Β 

Trading update

Β 

For the three months to 30 June 2012 (the 'Period'), the Group reported revenue growth of just over 1 per cent compared to the same period last year. As anticipated, the decline in retained revenues reported in the final quarter of the last financial year has impacted the first three months of trading in the current financial year, and as a consequence, like-for-like1 revenue for the first quarter was down just under 7 per cent, compared to the same period in 2011.

Β 

Communications

The Group's largest division, Communications, has performed broadly in line with the prior year in terms of first quarter revenue. TMW, the Nelson Bostock Group and The Real Adventure have all delivered growth in revenue with some significant new business wins. This new business includes: TMW being appointed to work on Sony Mobile's global social media strategy and winning projects from new clients such as BBC Good Food; the Nelson Bostock Group being hired by Cartoon Network; and The Real Adventure winning its first global account for Danone Baby Nutrition, helping the team to develop pioneering CRM strategies across Europe and beyond. EMO experienced a decline in first quarter revenue compared to the same prior year period due to the decline in retained revenues reported at the end of the last financial year, however, it too is experiencing an uplift in new business opportunities. The division overall, with its good new business performance and pipeline, and a full year effect of last year's cost reductions, is positioned for another year of growth.

Β 

Health

The stabilisation of the healthcare sector has continued and the division saw a small increase in like-for-like revenue during the first three months compared to the prior year period. The division is experiencing an increase in new business opportunities, winning more work from new and existing clients and while structural reform remains ongoing in the sector, the Group believes it is well placed to benefit from the resulting opportunities.

Β 

Insight

As previously reported ICM's performance in the last financial year has, as expected, continued to impact trading during the Period. Significant cost reduction actions were undertaken at the end of the last financial year and management will continue to review the business closely to ensure costs remain aligned to performance as revenue increases again. The wider division's focus on developing further expertise in new research technologies and digital platforms is creating good new business opportunities, and our healthcare focussed start-up company has added three new clients since the start of the new financial year.

Β 

Outlook

While on a like-for-like basis the Group has had a slower start to the new financial year, primarily as a result of the previously reported lower retained revenues at the end of the last financial year, there have been encouraging new business wins and opportunities across the Group.

Β 

The Board is pleased with the performance of its recent acquisition The Corkery Group and expects a positive impact from new client wins. However, we naturally remain cautious given the macro environment.

Β 

Β 

For further information please contact:

Β 

Creston plc

+ 44 (0)20 7930 9757

Don Elgie, Group Chief Executive

Barrie Brien, COO/CFO

M:Communications

+44 (0)20 7920 2339

Elly Williamson

Β 

About Creston plc

Creston plc (LSE: CRE) is a marketing services company focused on insight-led communications. The Group delivers a range of marketing services, including advertising, brand consultancy, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. Our insight companies give us a real edge, providing the analytic intelligence to enable us to truly understand, influence and inspire consumers and it's that insight-led intelligence that drives our creativity. www.creston.com


1 Excluding the results from any acquisitions made during the current year, like-for-like compares current year performance to the prior year, adjusting the current year to only include the results of prior year acquisitions for the commensurate period of ownership

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSEAAXEDSNAEAF
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.